Skip to main content
OpenTrials

Clinical trial condition

Chromosome Aberrations

Explore clinical trials studying Chromosome Aberrations. Study availability and eligibility vary by location and protocol.

100 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Chromosome Aberrations trial results

Completed

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

NCT01061177

Conditions
CML in Chronic Phase, Chromosome Aberrations, Hematologic Diseases, +8 more
Locations
  • Novartis Investigative Site Wels, Austria
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
View all 320 locations
View Trial Details
Completed

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

NCT01597063

Conditions
Abnormalities, Multiple, Aneuploidy, Chromosome Aberrations, +12 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • New Horizon Women's Care Chandler, Arizona, United States
  • Precision Trials Phoenix, Arizona, United States
  • Visions Clinical Research Tuscon Tucson, Arizona, United States
View all 27 locations
View Trial Details
Completed

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

NCT01555346

Conditions
Abnormalities, Multiple, Aneuploidy, Chromosome Aberrations, +14 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Visions Clinical Research Tuscon Tucson, Arizona, United States
  • Obstetrix Medical Group of California Campbell, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
View all 29 locations
View Trial Details
Completed

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

NCT01254188

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Novartis Investigative Site Algiers, Bouzareah, Algeria
  • Novartis Investigative Site Oran, Algeria
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
View all 100 locations
View Trial Details
Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Local Institution Jakarta, Indonesia
  • Local Institution Batangas, Philippines
  • Local Institution Manila, Philippines
  • Local Institution Busan, South Korea
View all 22 locations
View Trial Details

Related conditions